MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA)

CUSIP: G4444C102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -10,912,791
Total reported value: $0
Number of holders: 0
Value change: -$116,191,000
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP G4444C102?
CUSIP G4444C102 identifies HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q1 2022

Recent filing periods for CUSIP G4444C102:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

There are no holders of HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM as of Q2 2022.